Výsledky vyhledávání

Akademický článek

Serdexmethylphenidate/dexmethylphenidate for children with attention-deficit/hyperactivity disorder: dose optimization from a laboratory classroom study

Autor: Andrew J. Cutler, Scott H. Kollins, Matthew N. Brams, Meg Corliss, Charles Oh, Rene Braeckman, Ann C. Childress

Publikováno v: Frontiers in Psychiatry, Vol 15 (2024)

ObjectiveTo evaluate treatment responder rate using the Attention-Deficit/Hyperactivity Disorder Rating Scale-5 (ADHD-RS-5) score based on optimized dose level of serdexmethylphenidate/dexmethylphenidate (SDX/d-MPH) and changes in ADHD severity in ch

Externí odkaz: https://doaj.org/article/9df65ce3c2874ac88d12e6b98ba5c9f5

Zobrazit plný text záznamu

Analysis of Growth Velocity in Children with Attention-Deficit/Hyperactivity Disorder Treated for up to 12 Months with Serdexmethylphenidate/Dexmethylphenidate

Autor: Ann C. Childress, Andrew J. Cutler, Maitrey Patel, Charles Oh

Publikováno v: Journal of Child and Adolescent Psychopharmacology. 33:134-142

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::09716daca4775668baf33fe16c17c4fe
https://doi.org/10.1089/cap.2023.0012

Zobrazit plný text záznamu

Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study

Autor: Ann C. Childress, Andrea Marraffino, Andrew J. Cutler, Charles Oh, Matthew N. Brams

Publikováno v: Journal of Child and Adolescent Psychopharmacology. 33:51-58

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8a70404c27c51ab7800f4ded7f16f4cf
https://doi.org/10.1089/cap.2022.0076

Zobrazit plný text záznamu

A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder

Autor: Rene Braeckman, Andrew C. Barrett, Charles Oh, Matthew Brams, Sven Guenther, Scott H. Kollins, Andrew J. Cutler, Travis C. Mickle, Andrea Marraffino

Publikováno v: Journal of Child and Adolescent Psychopharmacology. 31:597-609

Objectives: To evaluate the efficacy and safety of once-daily serdexmethylphenidate/dexmethylphenidate (SDX/d-MPH) capsules (Azstarys™) compared with placebo in children with attention-deficit/hype...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9509b8c7b2435e25819369aa0f59e539
https://doi.org/10.1089/cap.2021.0077

Zobrazit plný text záznamu

Bioequivalence and safety comparison of once‐weekly donepezil transdermal system with oral donepezil: results of a phase 1 pharmacokinetic study in healthy volunteers

Autor: Pierre N. Tariot, Rene Braeckman, Charles Oh

Publikováno v: Alzheimer's & Dementia. 18

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c196506662a15ff7f41b5b6bb6d421e6
https://doi.org/10.1002/alz.068981

Zobrazit plný text záznamu

Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil

Autor: Pierre N. Tariot, Rene Braeckman, Charles Oh

Publikováno v: Journal of Alzheimer's disease : JAD. 90(1)

Background: Donepezil is approved for treatment of dementia of the Alzheimer type and is currently available only in tablet forms in the United States. Objective: To compare steady-state pharmacokinetics of once-weekly 10-mg/d and 5-mg/d Corplex™ d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e55d70b135584f7d6bc667cdfe4d733
https://pubmed.ncbi.nlm.nih.gov/36120781

Zobrazit plný text záznamu

Dose Proportionality and Steady-State Pharmacokinetics of Serdexmethylphenidate/Dexmethylphenidate, a Novel Prodrug Combination to Treat Attention-Deficit/Hyperactivity Disorder

Autor: Rene Braeckman, Sven Guenther, Travis C. Mickle, Andrew C. Barrett, Adam Smith, Charles Oh

Publikováno v: Journal of child and adolescent psychopharmacology. 32(5)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff5c0bac0876db572dc2a049932f187a
https://pubmed.ncbi.nlm.nih.gov/35666231

Zobrazit plný text záznamu

A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's disease

Autor: Michael Klingler, Angela Lee, Jenny Qian, Robert A. Hauser, Cheryl Waters, Monika Rudzińska, Eric S. Farbman, Peter A. LeWitt, Charles Oh

Publikováno v: Parkinsonism & Related Disorders. 81:144-150

Introduction CVT-301 (Inbrija®) is a levodopa inhalation powder for on-demand treatment of OFF episodes in Parkinson's disease patients treated with carbidopa/levodopa. Safety and efficacy results of a 12-month, dose-level blinded extension study of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b32f18701abd4338619bd8912a0c1edd
https://doi.org/10.1016/j.parkreldis.2020.10.029

Zobrazit plný text záznamu

Inhaled levodopa in Parkinson's disease patients with OFF periods: A randomized 12-month pulmonary safety study

Autor: Tanya Gurevich, Monika Rudzińska, Werner Poewe, Olivier Rascol, Jan Kassubek, Jennifer Cormier, Rohit Dhall, Charles Oh, Donald G. Grosset, Alexander Sedkov

Publikováno v: Parkinsonism & Related Disorders. 71:4-10

Introduction:\ud CVT-301 is an orally inhaled levodopa therapy approved for the intermittent treatment of OFF episodes in Parkinson's disease patients who are taking a standard oral levodopa regimen. This open-label, randomized, controlled study over

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88a90f2546fd6e03549ab496f3bc8dde
https://doi.org/10.1016/j.parkreldis.2019.12.012

Zobrazit plný text záznamu

Natural history of lung function over one year in patients with Parkinson's disease

Autor: Salvador Cangiamilla, Michael Klingler, Donald G. Grosset, David A. Kaminsky, Deena M. Kegler-Ebo, Ping Zhao, Charles Oh

Publikováno v: Respiratory medicine. 182

Background Little is known about decline in lung function in Parkinson's disease (PD). To assess these changes, we assessed the changes in lung function that occurred over 12 months in patients on standard PD therapy as part of the observational coho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ec87ea6a3825f9bc64097cef0d7d2c5
https://pubmed.ncbi.nlm.nih.gov/33866196

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání